Navigation Links
Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
Date:8/19/2007

- Early Antiviral Activity with HCV-796 Supports Follow-up with Standard of

Care Including Evaluation of Sustained Virologic Response (SVR) -

- Company to Host Conference Call at 10:00 AM ET Today -

EXTON, Pa., Aug. 10 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) announced today the decision made with Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), to discontinue dosing with HCV-796 in combination with pegylated interferon and ribavirin in its current Phase 2 study. All subjects, following consultation with the principal investigators at each site, will have the option of continuing on the combination therapy of pegylated interferon and ribavirin, the standard of care. This decision follows yesterday's review by the joint safety review board of safety data accumulated to date, which show elevated liver enzyme levels in some patients after 8 weeks or more of therapy with HCV-796 with pegylated interferon and ribavirin.

The companies conducted a thorough safety review of liver enzyme levels in all patients. Clinically significant elevations of liver enzymes were observed in approximately eight percent of patients receiving HCV-796, including two patients who experienced serious adverse events leading to withdrawal from active therapy with HCV-796, pegylated interferon and ribavirin. In contrast, elevated liver enzymes were seen in only one percent of patients on standard of care. Elevations of liver enzymes appear to be tran
'/>"/>

SOURCE ViroPharma Incorporated

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. New Information on the Potential of Plasmin Shared at ISTH Congress
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
5. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
6. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
7. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
8. Expert Opinion Highlights Avigens AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal
9. New Study Shows That telmisartan has Greater Renoprotective Potential Thanlosartan in Hypertensive Patients With Type 2 Diabetes
10. Pluristems PLX Cells Demonstrate Potential to Treat Parkinsons Disease
11. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  Valeant Pharmaceuticals International, Inc. ... announced it has completed the sale to Galderma of ... owned or held by Valeant for $1.4 billion in ... S.A, which recently completed its acquisition of Galderma. ... of our products to a company that is firmly ...
(Date:7/10/2014)... Decision Resources Group finds that over half ... and Drug Administration,s (FDA) approval of Vifor Fresenius Medical ... approved by the FDA in November 2013 for the ... on dialysis. Other key findings from the ... : , Bundling: ...
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... 10 Jefferson Radiology has acquired two Medical ... medical epicenter in north central Connecticut, and in ... expertise available at nine outpatient locations in the ... services at Hartford Hospital, Connecticut Children,s Medical Center, ...
... Ariz., Nov. 10 A recent national survey of 505 ... is important for a patient to seek treatment early to ... And 75 percent of pharmacists say most patients should purchase ... of symptoms, while only 26 percent of their patients take ...
Cached Medicine Technology:Jefferson Radiology Acquires Two Medical Imaging Center Offices 2Pharmacists Report Patients do not Treat Cold and Flu Symptoms Early Enough, New Survey Shows 2Pharmacists Report Patients do not Treat Cold and Flu Symptoms Early Enough, New Survey Shows 3
(Date:7/11/2014)... 2014 Recently, iFitDress.com, a leading online ... has released its new collection of evening dresses ... has announced that all these beautiful items are provided ... of the special offer is July 22. , ... pay close attention to customer satisfaction. On the company’s ...
(Date:7/11/2014)... H.E.A.R Me Out Listens to Needs ... week to provide comprehensive information and services available to ... million Coloradoans with hearing loss, this organization is the ... of the local and state resources that aims to ... , H.E.A.R. Me Out and its website was founded ...
(Date:7/11/2014)... Los Angeles dental implant expert ... and full mouth implants to replace missing teeth. Both ... dental implants from other tooth replacements: They replace the ... alone prevents the long-term complications of missing teeth, but ... comfort, appearance and systemic health. Mini implants broaden candidacy ...
(Date:7/11/2014)... 2014 Having experienced mental illness from the ... mental hospital staff, Roger Grainger gives readers an intimate look ... new book, “You Never Get Out.” , According to the ... Kingdom will experience some kind of mental health problem in ... to take a look at the way mental illness is ...
(Date:7/11/2014)... HealthDay Reporter FRIDAY, July 11, ... who can,t cough, sneeze or laugh without losing bladder ... cells to regenerate weakened urethra muscles. In a ... cells isolated from patients, own fat tissue improved or ... Stress incontinence affects about twice as many ...
Breaking Medicine News(10 mins):Health News:Worldwide Chic Ladies Can Buy Cheap Evening Dresses at iFitDress.com 2Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 2Health News:H.E.A.R Me Out Listens to Needs of Hearing Impaired 3Health News:Dental Implant Dentist, Kevin Sands DDS, Now Uses Mini and Full Mouth Implants to Replace Missing Teeth 2Health News:Psychiatric Hospital Patient and Registered Psychologist Explores Mental Health and Therapy in New Book "You Never Get Out" 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 2Health News:Stem Cells May Ease Urinary Incontinence, Study Says 3
... . , Scientists of the Center for Applied ... discovered the molecular mechanism responsible for the effectiveness of ... two substances in order to produce an effect that ... involved the role played by the AE2 protein when ...
... an early indicator of kidney dysfunction in adults may ... researchers have found. , Microalbuminuria, excessive amounts of albumin ... says Dr. Gregory Harshfield, director of the Medical College ... few studies that have looked at adolescent patients have ...
... Marini Skin Research,Inc. (JMSR; http://www.janmarini.com ) today ... new technology that addresses,common female transitional issues such ... and wrinkles, coarse skin texture and discoloration., ... acne,breakouts while dramatically improving the appearance of follicle ...
... Unique Skills Training Where Patients, Replicate Real-World Challenges in ... ... Personal Support, LOMA LINDA, Calif., Feb. 27 ... in physical,rehabilitation for survivors of stroke, fractures, amputations, brain,injuries, neurological ...
... The Alzheimer,s Foundation,of America (AFA) recently awarded grants ... that will enable them to,develop or enhance educational ... by Alzheimer,s disease and related dementias, and,their families., ... fund a variety of programs,including support services for ...
... Veterans a Sense of Purpose, WASHINGTON, Feb. 27 ... injured during Operation Iraqi,Freedom and Operation Enduring Freedom (OIF/OEF), ... Veterans Winter Sports Clinic in,Snowmass Village, March 30 - ... the physical, social, and emotional,well-being of the veterans who ...
Cached Medicine News:Health News:Cause of effectiveness discovered for a cirrhosis treatment useful in 40 percent of patients 2Health News:Urine protein may be present before hypertension diagnosis in at-risk adolescents 2Health News:Jan Marini Skin Research Introduces Age Intervention(R) Transitions - a New Frontier in Skin Care 2Health News:Loma Linda University Medical Center Celebrates Groundbreaking on Inland Empire's Most Comprehensive Rehabilitation Center 2Health News:Loma Linda University Medical Center Celebrates Groundbreaking on Inland Empire's Most Comprehensive Rehabilitation Center 3Health News:Alzheimer's Foundation of America Awards Grants to Local Groups Nationwide 2Health News:World's Largest Disabled Ski Clinic at Snowmass, Colo. 2
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: